P505 Real-world short-term effectiveness of ustekinumab in Crohn’s disease: Results from the ENEIDA Registry by Iborra, M, Beltrán, B, Fernández, A, Gutiérrez, A, Antolín, B, Huguet, J M, de Francisco, R, Merino, O, Carpio, D, García López, S, Mesonero, F, Mínguez, M, Ferreiro, R, Carbajo, A Y, Rivero, M, Chaparro, M, Piñero-Pérez, M C, Monfort i Miquel, D, Bujanda, L, García-Sepulcre, M F, Martín-Cardona, A, Cañete, F, Taxonera, C, Sierra-Ausin, M, Ferrer-Rosique, J Á, Martín-Arranz, M D, González-Muñosa, C, Manceñido-Marcos, N, Rodríguez-Lago, I, Iglesias-Flores, E, Forés-Bosch, A, Navarro-Llavat, M, Calafat, M, Madrigal-Domínguez, R E, Ramos, L, Arroyo, M, Busquets, D, Lorente, R, Saiz-Arnau, E, Hernández-Camba, A, Jair-Morales, V, Paredes, C, Van Domselaar, M, Hervás, D, Cañada-Martínez, A, Nos, P

Get full text

N032 Impact of pain due to subcutaneous administration of a biological drug by Gely, C, Marin, L, Gordillo, J, Mañosa, M, Bertoletti, F, Cañete, F, Gonzalez-Muñosa, C, Cabré, E, Domènech, E, Garcia-Planella, E

Get full text